EG622744 Activators
Pramel53, a PRAME-like 53 gene predominantly active in the cytoplasm and integral to the cell membrane, remains a relatively unexplored facet of cellular physiology. Its predicted functions suggest involvement in crucial cellular processes yet to be comprehensively unraveled. Understanding its activation mechanisms is pivotal for deciphering its role in cellular homeostasis. The target's predicted cytoplasmic activity implies a potential role in intracellular signaling cascades, perhaps modulating pathways associated with cell growth, metabolism, or response to external stimuli. Additionally, its integration into the cell membrane suggests a connection to membrane-bound signaling events. Pramel53's intricate positioning within the cell underscores its significance in orchestrating cellular responses.
Activation of Pramel53 is intricately linked to various biochemical and cellular pathways. The chemicals outlined in the table act as modulators, either directly or indirectly, influencing the protein's activity. Sodium Orthovanadate, for instance, indirectly activates Pramel53 by inhibiting phosphatases, leading to sustained activation of growth factor signaling. Similarly, other chemicals impact cellular processes, such as epigenetic regulation, chromatin modification, and modulation of signaling cascades, contributing to the intricate network governing Pramel53 activation. In conclusion, Pramel53 stands as a fascinating and complex player in cellular physiology, with its activation intricately regulated by a network of signaling pathways and cellular processes. Further exploration into the specifics of these mechanisms promises to unveil the full extent of Pramel53's functional repertoire within the cellular landscape.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $49.00 $57.00 $187.00 | 142 | |
A potent inhibitor of protein tyrosine phosphatases, including PTP1B. By inhibiting phosphatases, it leads to sustained activation of receptor tyrosine kinases, particularly those associated with growth factor signaling, indirectly promoting Pramel53 activity through enhanced signal transduction. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Activates AMP-activated protein kinase (AMPK), a key regulator of cellular energy homeostasis. Indirectly up-regulates Pramel53 by modulating AMPK, which influences cellular processes linked to Pramel53 activation, such as autophagy and metabolism. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor that induces DNA demethylation. Epigenetically regulates Pramel53 expression by removing methyl groups from its promoter region, leading to increased transcriptional activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Selective inhibitor of p38 MAPK. Modulates the MAPK pathway, affecting downstream targets. The inhibition of p38 MAPK indirectly influences Pramel53 by altering the cellular environment and signaling cascades linked to its regulation. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
HDAC inhibitor that modulates chromatin structure. Indirectly influences Pramel53 expression by promoting an open chromatin state, allowing for increased accessibility of transcriptional machinery to the gene locus. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Proteasome inhibitor affecting protein degradation pathways. By preventing the degradation of certain proteins, it indirectly influences the cellular milieu, impacting pathways associated with Pramel53 regulation. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
PI3-kinase inhibitor disrupting the PI3K/Akt signaling pathway. Indirectly regulates Pramel53 by modulating downstream signaling cascades, affecting cellular processes related to its activation. | ||||||
A-769662 | 844499-71-4 | sc-203790 sc-203790A sc-203790B sc-203790C sc-203790D | 10 mg 50 mg 100 mg 500 mg 1 g | $184.00 $741.00 $1076.00 $3417.00 $5304.00 | 23 | |
AMP-activated protein kinase (AMPK) activator. Directly stimulates AMPK, influencing cellular energy balance and indirectly impacting Pramel53 through energy-sensitive pathways. | ||||||
Niclosamide | 50-65-7 | sc-250564 sc-250564A sc-250564B sc-250564C sc-250564D sc-250564E | 100 mg 1 g 10 g 100 g 1 kg 5 kg | $38.00 $79.00 $188.00 $520.00 $1248.00 $5930.00 | 8 | |
Inhibitor of Wnt/β-catenin pathway. Modulates cellular processes linked to Wnt signaling, indirectly affecting Pramel53 expression and activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3-kinase inhibitor disrupting PI3K/Akt pathway. By inhibiting PI3-kinase, it indirectly regulates Pramel53 through downstream effects on cellular processes and signaling cascades. | ||||||